Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative S-1/CPT-11 Combination Chemotherapy in Locally Advanced Gastric Cancer
NCT00134095Phase 2Unknown
- Sponsor
- Fukushima Medical University Hospital
- Start
- Sep 2004
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur-gimeracil-oteracil, irinotecan in gastric cancer (GC), sponsored by Fukushima Medical University Hospital. Status: unknown.
02
Drugs
tegafur-gimeracil-oteracilirinotecan
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00134095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134095.